The SWISS concept product line builds on a shared foundation: Swiss Platelet Gel Life (SPGL) tubes for gel separation and ProtSmart ultrafiltration technology from Medica S.p.A. Each product is configured for a different clinical need.
The SWISS concept
Every SWISS concept product starts with Swiss Platelet Gel Life (SPGL) tubes — proprietary gel separation tubes that isolate platelet-rich plasma from red blood cells in a single centrifugation step. No double-spin. No buffy coat harvesting. No operator-dependent pipetting.
Two of the four products add a second step: ultrafiltration through a ProtSmart device (Medica S.p.A., Medolla, Italy). The ProtSmart membrane removes only plasma water and small solutes (below 15 kDa) while retaining platelets, plasma proteins, growth factors, and extracellular vesicles. This is the zero-loss concentration principle — nothing therapeutic is discarded.
The result: four products spanning the full spectrum of autologous biological therapy, from a simple injectable PRP to a fully characterized biological concentrate.
THE FOUR PRODUCTS
autologIX by SWISS concept
48 mL of blood is processed with ProtSmart 6 ultrafiltration to yield 6–7 mL of concentrated autologous biological product rich in exosomes, proteins, growth factors, platelets, and fibrin precursors.
Designed for higher-volume applications such as joints, spine, wound care, and surgery, with exosome content characterized by three methods and aligned with MISEV2023.
PCX by SWISS concept
24 mL of blood is processed with ProtSmart 2 ultrafiltration to produce 3–4 mL of concentrated platelet and protein-rich biological product.
Designed for aesthetics, hair restoration, dental procedures, and small-joint injections where compact, high-recovery concentrate is needed.
PRP by SWISS concept
SPGL tubes with anticoagulant and separator gel use a single centrifugation step to produce leukocyte-poor PRP with no ultrafiltration or manual pipetting required.
Designed for practitioners seeking a simple, fast, and reproducible PRP preparation ready for immediate clinical use.
PRF by SWISS concept
A specialized SPGL tube without anticoagulant or separator gel uses a single 4-minute spin to produce injectable platelet-rich fibrin (iPRF) with a natural fibrin matrix rich in platelets, leukocytes, and growth factors.
Designed for surgical augmentation, socket preservation, soft tissue grafting, and procedures benefiting from sustained growth factor release.
Shared
Shared technology across the SWISS concept line
All four products use Swiss Platelet Gel Life (SPGL) tubes and single-spin gel separation. They differ in whether ultrafiltration is added, what tube variant is used, and what the output contains.
SWISS PLATELET GEL LIFE (SPGL) TUBES
Proprietary gel separation tubes manufactured for Biological Innovations. The thixotropic separator gel migrates during centrifugation, forming a physical barrier that retains red blood cells and granulocytes below while platelets and plasma proteins stratify above. Single spin. Minimal operator dependency.
PROTSMART ULTRAFILTRATION (PCX and autologIX only)
Hollow-fiber ultrafiltration devices manufactured by Medica S.p.A. (Medolla, Italy). MediSulfone® polysulfone membrane with 15 kDa molecular weight cutoff. Removes plasma water and small solutes; retains everything above the cutoff: platelets, plasma proteins, growth factors, cytokines, and extracellular vesicles. Two configurations: ProtSmart 2 (for PCX) and ProtSmart 6 (for autologIX).
NO SPECIALIZED
EQUIPMENT
All SWISS concept products require only a standard laboratory centrifuge — equipment already present in most clinical settings. No proprietary PRP centrifuge, no automated system, no capital equipment investment.
